Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients.
AIMS:There is controversy in the guidelines as to whether patients with atrial fibrillation and a low risk of stroke should be treated with anticoagulation, especially those with a CHA2DS2-VASc score of 1 point. METHODS:In a retrospective, nationwide cohort study, we used the Swedish National Patien...
Main Authors: | Tommy Andersson, Anders Magnuson, Ing-Liss Bryngelsson, Ole Frøbert, Karin M Henriksson, Nils Edvardsson, Dritan Poçi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5417522?pdf=render |
Similar Items
-
All-cause mortality trends in patients hospitalized for atrial fibrillation in Sweden: Role of age, stroke risk, and education
by: Áron Sztaniszláv, et al.
Published: (2022-12-01) -
Comparison of the Safety and Efficacy of Warfarin Versus Rivaroxaban in Northern Chinese Patients with Different CHA2DS2-VASc Scores: A Retrospective Cohort Study
by: Shiwei Xu, et al.
Published: (2023-04-01) -
Prediction of coronary artery disease severity using CHADS2, CHA2DS2-VASC scores and a newly defined CHA2DS2-VASC-HS and CHA2DS2-VASC-HSF scores
by: Ranjan Modi, et al.
Published: (2014-11-01) -
Oral anticoagulant therapy in a patient with CHA₂DS₂-VASc score 1
by: Stefania Cherubini, et al.
Published: (2018-11-01) -
Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA2DS2VASC score: CCHA2DS2VASC score
by: Brandon Bungo, et al.
Published: (2022-08-01)